• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preoperative risk score for access site failure in ultrasound-guided percutaneous aortic procedures.超声引导经皮主动脉介入治疗中入路失败的术前风险评分。
J Vasc Surg. 2019 Oct;70(4):1254-1262.e1. doi: 10.1016/j.jvs.2018.12.025. Epub 2019 Mar 7.
2
Outcomes of Open Versus Percutaneous Access for Patients Enrolled in the GREAT Registry.GREAT 注册研究中经皮入路与开放入路患者结局比较。
Ann Vasc Surg. 2021 Jan;70:370-377. doi: 10.1016/j.avsg.2020.06.033. Epub 2020 Jun 27.
3
Percutaneous versus femoral cutdown access for endovascular aneurysm repair.经皮穿刺与股动脉切开入路用于血管内动脉瘤修复术
J Vasc Surg. 2015 Jul;62(1):16-21. doi: 10.1016/j.jvs.2015.01.058. Epub 2015 Mar 28.
4
Cutdown is Associated with Higher 30-day Unplanned Readmissions and Wound Complications than Percutaneous Access for EVAR.相比于经皮血管内介入治疗(EVAR),切开入路与更高的 30 天非计划性再入院率和伤口并发症相关。
Ann Vasc Surg. 2024 Sep;106:1-7. doi: 10.1016/j.avsg.2024.02.016. Epub 2024 Apr 8.
5
Ultrasound-guided percutaneous endovascular aneurysm repair success is predicted by access vessel diameter.超声引导经皮血管内动脉瘤修复术的成功与入路血管直径相关。
J Vasc Surg. 2012 Jun;55(6):1554-61. doi: 10.1016/j.jvs.2011.12.042. Epub 2012 Feb 22.
6
The Kaiser Permanente experience with ultrasound-guided percutaneous endovascular abdominal aortic aneurysm repair.凯撒医疗集团在超声引导下经皮血管腔内腹主动脉瘤修复方面的经验。
Ann Vasc Surg. 2012 Oct;26(7):906-12. doi: 10.1016/j.avsg.2011.09.013. Epub 2012 Apr 24.
7
Safety and effectiveness of total percutaneous access for fenestrated endovascular aortic aneurysm repair.开窗式血管腔内主动脉瘤修复术完全经皮入路的安全性和有效性
J Vasc Surg. 2016 Oct;64(4):896-901. doi: 10.1016/j.jvs.2016.03.444. Epub 2016 May 27.
8
Preoperative Risk Factors for Access Site Failure in Ultrasound-Guided Percutaneous Treatment of TASC C and D Aorto-Iliac Occlusive Disease.超声引导下经皮治疗 TASC C 和 D 型主髂动脉闭塞性疾病中入路失败的术前危险因素。
Ann Vasc Surg. 2022 Feb;79:130-138. doi: 10.1016/j.avsg.2021.06.048. Epub 2021 Oct 10.
9
Two-year evaluation of fenestrated and parallel branch endografts for the treatment of juxtarenal, suprarenal, and thoracoabdominal aneurysms at a single institution.单中心 2 年随访结果:采用开窗及分支型覆膜支架治疗肾周、肾上及胸腹主动脉瘤。
J Vasc Surg. 2020 Jan;71(1):15-22. doi: 10.1016/j.jvs.2019.03.058. Epub 2019 Nov 9.
10
The Safety and Effectiveness of the Prostar XL Closure Device Compared to Open Groin Cutdown for Endovascular Aneurysm Repair.Prostar XL 封堵装置与开放腹股沟切开术治疗血管内动脉瘤修复的安全性和有效性比较。
Vasc Endovascular Surg. 2023 Nov;57(8):848-855. doi: 10.1177/15385744231180663. Epub 2023 Jun 5.

引用本文的文献

1
Optimizing Femoral Access in Emergency EVAR with a Decision-Making Algorithm.使用决策算法优化急诊腹主动脉瘤腔内修复术中的股动脉入路
Life (Basel). 2024 Sep 4;14(9):1113. doi: 10.3390/life14091113.
2
Predictors of 30-Day Postoperative Outcome after Elective Endovascular Abdominal Aortic Aneurysm Repair: A Tertiary Referral Center Experience.择期血管内腹主动脉瘤修复术后30天预后的预测因素:三级转诊中心经验
J Clin Med. 2023 Sep 16;12(18):6004. doi: 10.3390/jcm12186004.
3
Access challenge in patient with ruptured infrarenal abdominal aneurysm treated with modified contralateral iliac limb technique.采用改良对侧髂支技术治疗破裂性肾下腹主动脉瘤患者的入路挑战
J Vasc Surg Cases Innov Tech. 2023 Apr 3;9(2):101172. doi: 10.1016/j.jvscit.2023.101172. eCollection 2023 Jun.
4
Safety of Percutaneous Femoral Access for Endovascular Aortic Aneurysm Repair Through Previously Surgically Exposed or Repaired Femoral Arteries.经手术暴露或修复的股动脉行经皮股动脉入路行血管内主动脉瘤修复的安全性。
J Endovasc Ther. 2023 Oct;30(5):730-738. doi: 10.1177/15266028221092980. Epub 2022 May 6.
5
Percutaneous Axillary Access for Placement of Microaxial Ventricular Support Devices: The Axillary Access Registry to Monitor Safety (ARMS).经皮腋窝入路植入微轴心室支持装置:监测安全性的腋窝入路注册研究(ARMS)。
Circ Cardiovasc Interv. 2021 Jan;14(1):e009657. doi: 10.1161/CIRCINTERVENTIONS.120.009657. Epub 2020 Dec 16.

本文引用的文献

1
Local anesthesia for percutaneous endovascular abdominal aortic aneurysm repair is associated with fewer pulmonary complications.局部麻醉用于经皮腔内血管腹主动脉瘤修复术与较少的肺部并发症相关。
J Vasc Surg. 2018 Oct;68(4):1023-1029.e2. doi: 10.1016/j.jvs.2017.12.064. Epub 2018 Mar 27.
2
Successful percutaneous access for endovascular aneurysm repair is significantly cheaper than femoral cutdown in a prospective randomized trial.在一项前瞻性随机试验中,血管内动脉瘤修复的经皮成功入路明显比股动脉切开术更便宜。
J Vasc Surg. 2018 Aug;68(2):384-391. doi: 10.1016/j.jvs.2017.12.052. Epub 2018 Mar 8.
3
Comparison of access type on perioperative outcomes after endovascular aortic aneurysm repair.血管内主动脉瘤修复术后围手术期结局的入路类型比较。
J Vasc Surg. 2018 Jul;68(1):91-99. doi: 10.1016/j.jvs.2017.10.075. Epub 2018 Jan 17.
4
Outcomes of total percutaneous endovascular aortic repair for thoracic, fenestrated, and branched endografts.全经皮血管腔内主动脉修复术治疗胸主动脉、开窗型和分支型腔内移植物的疗效。
J Vasc Surg. 2015 Dec;62(6):1442-9.e3. doi: 10.1016/j.jvs.2015.07.072. Epub 2015 Sep 12.
5
Percutaneous versus femoral cutdown access for endovascular aneurysm repair.经皮穿刺与股动脉切开入路用于血管内动脉瘤修复术
J Vasc Surg. 2015 Jul;62(1):16-21. doi: 10.1016/j.jvs.2015.01.058. Epub 2015 Mar 28.
6
Routine use of ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates.在周围血管介入治疗的股动脉穿刺中常规使用超声引导可降低腹股沟血肿发生率。
J Vasc Surg. 2015 May;61(5):1231-8. doi: 10.1016/j.jvs.2014.12.003. Epub 2015 Jan 13.
7
Predictors of Failure of Closure in Percutaneous EVAR Using the Prostar XL Percutaneous Vascular Surgery Device.使用Prostar XL经皮血管手术装置进行经皮腔内血管成形术(EVAR)时封堵失败的预测因素。
Eur J Vasc Endovasc Surg. 2015 Jan;49(1):45-9. doi: 10.1016/j.ejvs.2014.10.017.
8
Routine use of ultrasound-guided access reduces access site-related complications after lower extremity percutaneous revascularization.常规使用超声引导下穿刺可减少下肢经皮血管重建术后与穿刺部位相关的并发症。
J Vasc Surg. 2015 Feb;61(2):405-12. doi: 10.1016/j.jvs.2014.07.099. Epub 2014 Sep 18.
9
A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial).多中心、随机、对照临床试验,评估经皮入路与开放股动脉入路在血管内主动脉瘤修复术中的应用(PEVAR 试验)。
J Vasc Surg. 2014 May;59(5):1181-93. doi: 10.1016/j.jvs.2013.10.101. Epub 2014 Jan 17.
10
Femoral artery calcification as a determinant of success for percutaneous access for endovascular abdominal aortic aneurysm repair.股动脉钙化是经皮腔内腹主动脉瘤修复术成功的决定因素。
J Vasc Surg. 2013 Nov;58(5):1208-12. doi: 10.1016/j.jvs.2013.05.028. Epub 2013 Jul 2.

超声引导经皮主动脉介入治疗中入路失败的术前风险评分。

Preoperative risk score for access site failure in ultrasound-guided percutaneous aortic procedures.

机构信息

Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.

Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.

出版信息

J Vasc Surg. 2019 Oct;70(4):1254-1262.e1. doi: 10.1016/j.jvs.2018.12.025. Epub 2019 Mar 7.

DOI:10.1016/j.jvs.2018.12.025
PMID:30852039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6731168/
Abstract

OBJECTIVE

The factors associated with access site failure after ultrasound-guided percutaneous access for aortic endograft procedures remain poorly characterized. We developed a prediction model to risk stratify patients for access site failure.

METHODS

We performed a retrospective institutional review of consecutive patients who underwent endovascular aneurysm repair (EVAR), fenestrated EVAR (FEVAR), or thoracic endovascular aortic repair (TEVAR) from 2014 to 2016. We excluded patients undergoing direct aortic access through sternotomy and patients treated with physician-modified endografts, given reporting restrictions. Our primary outcome was groin access site failure, which included bleeding and thrombosis. An 8-point risk model was created for access site failure using multivariable fractional polynomials and internally validated using bootstrapping.

RESULTS

We identified 469 femoral arteries from 247 patients undergoing endovascular aortic repair procedures (EVAR, 75%; FEVAR, 8.0%; TEVAR, 17%). Surgeons performed percutaneous access in 97.2% of the femoral arteries, with 99.6% ultrasound use. Twenty-seven (5.9%) access site failures occurred (17 bleeding, 10 thrombosis), all treated with groin cutdown, for a successful percutaneous femoral artery access rate of 94%. Of the 215 patients with attempted bilateral percutaneous access, 90% had successful bilateral access. However, FEVAR had lower rates of successful bilateral access (FEVAR, 78%; EVAR, 91%; TEVAR, 94%; P = .03). Factors independently associated with percutaneous access site failure were femoral artery outer wall diameter (per millimeter increase: odds ratio [OR], 0.003 [0.0002-0.1]; P < .001), femoral artery stenosis >50% (OR, 22.3 [2.7-183.2]; P < .01), and urgent/emergent intervention (OR, 3.6 [1.2-11.0]; P = .03). A risk prediction model based on these criteria produced a C statistic of 0.89, a Hosmer-Lemeshow goodness of fit of 0.99, and a Brier score of 0.04. Excluding treatment for ruptured aneurysms, cutdown for access failure and planned initial groin cutdown resulted in longer postoperative lengths of stay and higher rates of access-related readmission, return to operating room, groin infection, and myocardial infarction compared with successful percutaneous access. There was no difference in major adverse events between planned initial groin cutdown and cutdown after failure; however, the small number of patients in these two comparison groups limits the statistical power to detect a difference.

CONCLUSIONS

Percutaneous ultrasound-guided access can be safely performed in almost all patients undergoing endovascular aortic procedures, but access site failures do occur. This risk score can help users select patients with high likelihood of success, identify patients who need close scrutiny with postclosure femoral duplex ultrasound, and provide patient guidance about risk of unplanned groin cutdown.

摘要

目的

经超声引导经皮入路行主动脉覆膜支架腔内修复术(endovascular aortic repair,EVAR)后,股动脉入路失败的相关因素仍未得到充分描述。我们开发了一种预测模型来对股动脉入路失败的风险进行分层。

方法

我们对 2014 年至 2016 年间连续接受血管内动脉瘤修复术(endovascular aneurysm repair,EVAR)、开窗式 EVAR(fenestrated EVAR,FEVAR)或胸主动脉腔内修复术(thoracic endovascular aortic repair,TEVAR)的患者进行了回顾性的机构审查。我们排除了经胸骨切开术直接进行主动脉入路的患者和接受医生改良内支架的患者,因为存在报告限制。我们的主要结局是股动脉入路失败,包括出血和血栓形成。使用多变量分数多项式创建了一个 8 分的股动脉入路失败风险模型,并通过自举法进行内部验证。

结果

我们从 247 名接受血管内主动脉修复术的患者中确定了 469 条股动脉(EVAR,75%;FEVAR,8.0%;TEVAR,17%)。外科医生在 97.2%的股动脉中进行了经皮入路,99.6%使用了超声。27 例(5.9%)发生了股动脉入路失败(17 例出血,10 例血栓形成),均通过股动脉切开术进行了治疗,股动脉经皮入路成功率为 94%。在 215 例尝试双侧经皮入路的患者中,90%有双侧成功入路。然而,FEVAR 的双侧经皮入路成功率较低(FEVAR,78%;EVAR,91%;TEVAR,94%;P=0.03)。与经皮股动脉入路失败相关的独立因素是股动脉外壁直径(每毫米增加:比值比[OR],0.003[0.0002-0.1];P<0.001)、股动脉狭窄>50%(OR,22.3[2.7-183.2];P<0.01)和紧急/急诊干预(OR,3.6[1.2-11.0];P=0.03)。基于这些标准的风险预测模型产生了 0.89 的 C 统计量、0.99 的 Hosmer-Lemeshow 拟合优度和 0.04 的 Brier 评分。排除破裂动脉瘤的治疗、因入路失败而进行的切开术和计划的初始股动脉切开术,与成功的经皮入路相比,术后住院时间更长,与入路相关的再入院、重返手术室、股动脉感染和心肌梗死的发生率更高。计划的初始股动脉切开术和切开术失败后股动脉切开术之间的主要不良事件没有差异;然而,这两个比较组中的患者数量较少,限制了检测差异的统计能力。

结论

经超声引导的经皮入路几乎可以安全地应用于所有接受血管内主动脉手术的患者,但股动脉入路仍会失败。该风险评分有助于使用者选择有较高成功率的患者,识别需要密切监测股动脉闭合后超声的患者,并为患者提供关于计划外股动脉切开术风险的指导。